HCPC Europe Columbus Award for
Compliance Enhancing Packaging Design 2015

Each year HCPC Europe organises the Columbus Packaging award for patient compliance/adherence enhancing pack design. Innovative packaging solutions help patients to take their medication as prescribed. Carefully designed packaging can make a significant contribution to patient compliance with respect to: e.g. ease of identification; clarity of instructions; visible evidence of medication taken.

The winner of the Columbus Award 2015 is the Cimzia® pack of UCB Pharma S.A. and Rondo AG. Out of a large number of entries the jury chose two finalists, who presented their packs at the award ceremony on 29 October 2015 at Kloster Eberbach.

Columbus Packaging Award 2015

On 29 October 2015 the award ceremony for the Columbus Award 2015 took place. With this award HCPC Europe awards excellent packaging design that improves patient adherence.

Register for the Columbus Award 2016

Registration for the Columbus Award 2016 is now open! For more information, send an e-mail to Ger Standhardt.

Winner
Columbus Award 2015

Rondo AG and UCB Pharma S.A.

Cimzia® (certolizumab pegol) is a tumor necrosis factor (TNF) blocker indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). In cooperation with UCB, Rondo worked on the development of a patient compliant packaging which can be easily handled by persons with RA. Most patients have difficulties in safely opening standard folding boxes. For what relates to packaging, the vision is to be the best in class provider of innovative or cutting edge packaging solutions to patients, and to deliver solutions inspired by actionable insights. UCB envision design, and deliver creative packaging solutions that connect to patients on a functional and emotional level. This packaging solution was successfully launched in EU and IMM countries where it is now used by UCB’s patients.

Finalist
Columbus Award 2015

Novartis

Novartis has developed a new blister design for its diabetes product Eucreas. It features a blister size reduction, to improve mobility and convenience, and a separable daily dose. The sun/moon print supports patient adherence to the therapy and the blister has notches with rounded corners to support tearing off the daily dose.